Although DCBLD2 expression is reduced in human CAVD, the genetic basis of the majority of CAVD and BAV cases remains to be determined, and to date, linkage analyses have not identified any DCBLD2 sequence variation in human BAV. This evidence concerns the gene DCBLD2 and congenital bilateral aplasia of vas deferens from CFTR mutation.